Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 20 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT06737913
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- Gansu Province Cancer Hospital Lanzhou, Gansu, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
- Henan Cancer Hospital Zhengzhou, Henan, China
NCT07493044
- Conditions
- Adenocarcinoma, Advanced Hepatocellular Carcinoma (HCC), Carcinoma, +10 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Gaungdong, China
NCT07147101
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China
NCT07500220
- Conditions
- Advanced Hepatocellular Carcinoma (HCC), Digestive System Diseases, Digestive System Neoplasms, +6 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
Phase 2 Study of WGI-0301 for Advanced HCC
NCT06309485
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- China Pharmaceutical University, Shanghai Gobroad Cancer Hospital Shanghai, Shanghai Municipality, China
- West China Hospital Sichuan University Chengdu, China
- Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou, China
- Prince of Wales Hospital Hong Kong
A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)
NCT07039201
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
- First Affiliated Hospital, Medical College of Zhejiang University Hangzhou, Zhejiang, China
NCT06828380
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- National Cancer Center Goyang, South Korea
- Samsung Medical Center, Seoul Seoul, South Korea
NCT06902389
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- The Third Affiliated Hospital of Navy Military Medical University Shanghai, Yangpu District, China
NCT07123545
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
NCT06995105
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- the First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Phase 2 Study of WGI-0301 Plus Lenvatinib in Patients With Advanced HCC
NCT07540832
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
Not specified
Use of Immune Checkpoint Inhibitors in Patients With Advanced Hepatocellular Carcinoma : Efficacy and Outcomes
NCT07321067
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- Sohag university hospitals Sohag, Sohag Governorate, Egypt
- sSohag oncology centre Sohag, Sohag Governorate, Egypt
Safety and Efficacy of Paclitaxel Liposome Arterial Infusion Combined With Systemic Therapy for Second-Line Treatment of Advanced Liver Cancer
NCT07282509
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
Not specified
Effect of Prehabilitation During the Conversion Therapy on Postoperative Outcomes in Unresectable Hepatocellular Carcinoma
NCT06749678
- Conditions
- Advanced Hepatocellular Carcinoma (HCC), Prehabilitation
- Locations
-
- Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
NCT04723004
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- The First Affiliated Hospital of Bengbu Medical college Bengbu, Anhui, China
- Anhui Cancer Hospital Hefei, Anhui, China
- Anhui Provincial Hospital Hefei, Anhui, China
- The Second Hospital of Anhui Medical University Hefei, Anhui, China
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- Beijing Cancer hospital Beijing, China
NCT02906397
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC
NCT02814461
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- Shin Kong Wu Ho-Su Memorial Hospital Taipei, Taiwan
Phase III Study of Toripalimab(JS001) Combined With Lenvatinib for Advanced HCC
NCT04523493
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- Qinhuai Medical Area, General Hospital of PLA Eastern Theater Command Nanjing, Jiangsu, China
- Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico,Oncologia Medica Milan, Italy
- IRCCS Fondazione Giovanni Pascale, Istituto Nazionale Dei Tumori Naples, Italy
- Azienda Ospedaliero Universitaria Pisana Pisa, Italy
A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)
NCT04344158
- Conditions
- Advanced Hepatocellular Carcinoma (HCC)
- Locations
-
- The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
- Anhui Provincial Hospital Hefei, Anhui, China
- The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
- Anhui Provincial Cancer Hospital Hefei, Anhui, China